Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

6.1K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
6.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

12.1K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Introduction to Hemostasis01:05

Introduction to Hemostasis

11.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.4K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early versus delayed EKOS thrombolysis in intermediate-high risk pulmonary embolism: a retrospective multicentre analysis.

Open heart·2026
Same author

Audiovisual Distraction During Mitral Transcatheter Edge-to-Edge Repair: A Sedation-Sparing Randomized Trial.

JACC. Advances·2026
Same author

Targeting hypertension with SGLT2 inhibition: the EU-funded SGLT2 HYPE trial.

European heart journal·2026
Same author

Dynamic changes in mean corpuscular volume could be integrated into longitudinal prediction frameworks for individualized risk assessment in the ICU setting: A retrospective study.

Science progress·2026
Same author

ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study.

Frontiers in immunology·2026
Same author

Heart failure prevalence and incidence in Germany: National data on medical therapy and comorbidities.

International journal of cardiology·2026
Same journal

Ursodeoxycholic acid inhibits platelet activation and thrombosis via TREM2: Evidence from mouse models and human studies.

British journal of pharmacology·2026
Same journal

Peripheral κ opioid receptor in pain and inflammation: From molecular signalling and gene expression to drug discovery.

British journal of pharmacology·2026
Same journal

Targeting KRAS for cancer therapy.

British journal of pharmacology·2026
Same journal

Fangchinoline alleviates hypertensive heart failure via PGC-1α/STAT6/PPARγ activation of mitophagy against ferroptosis.

British journal of pharmacology·2026
Same journal

The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells.

British journal of pharmacology·2026
Same journal

Immune checkpoint inhibitor-induced arrhythmias: Mechanistic insights from clinical and preclinical studies.

British journal of pharmacology·2026
See all related articles

Related Experiment Video

Updated: Nov 10, 2025

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.6K

Complement, inflammation and thrombosis.

Elias Rawish1,2,3, Manuela Sauter1, Reinhard Sauter1,3

  • 1Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.

British Journal of Pharmacology
|April 5, 2021
PubMed
Summary
This summary is machine-generated.

The innate immune system, specifically the complement system, influences blood clot formation by interacting with platelets. Understanding this interplay is crucial for diseases involving both thrombosis and complement activation.

Keywords:
InflammationInnate immunitycardiovascular diseasecoagulationcomplementleukocytesplatelets

More Related Videos

Depletion of Specific Cell Populations by Complement Depletion
06:17

Depletion of Specific Cell Populations by Complement Depletion

Published on: February 5, 2010

22.4K
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

11.8K

Related Experiment Videos

Last Updated: Nov 10, 2025

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.6K
Depletion of Specific Cell Populations by Complement Depletion
06:17

Depletion of Specific Cell Populations by Complement Depletion

Published on: February 5, 2010

22.4K
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

11.8K

Area of Science:

  • Immunology
  • Hematology
  • Thrombosis

Background:

  • A complex relationship exists between immune system activation and the development of blood clots (thrombus formation).
  • Components of the innate immune response, such as the complement system, can significantly impact platelet activation and subsequent thrombus development.
  • Specific complement components, including C3 and the membrane attack complex, have been observed to associate with platelets and exhibit functional activity during platelet activation.

Purpose of the Study:

  • To review the current understanding of the interaction between the complement system and platelet activation in thrombus formation.
  • To explore the regulatory mechanisms governing this interplay and its implications for tissue inflammation, damage, and repair.
  • To contextualize these findings within diseases characterized by concurrent thrombosis and complement activation.

Main Methods:

  • Literature review of existing research on complement-platelet interactions.
  • Analysis of studies investigating the role of complement components in thrombosis.
  • Synthesis of information on diseases involving both thrombosis and complement activation.

Main Results:

  • The complement system directly modulates platelet activation, influencing thrombus formation.
  • Evidence suggests functional activity of complement components like C3 and the membrane attack complex in the platelet microenvironment.
  • The precise mechanisms and downstream consequences of this immune-platelet crosstalk require further elucidation.

Conclusions:

  • The interaction between the complement system and platelets is a key factor in thrombus formation.
  • Further research is needed to fully define the regulatory pathways and pathological significance of this interaction.
  • Understanding this relationship is vital for developing therapeutic strategies for diseases with both thrombotic and inflammatory components.